Sage shares surge as depression drug succeeds in mid-stage trial

loading...


Sage shares surge as depression drug succeeds in mid-stage trial
(Reuters) – Drug developer Sage Therapeutics Inc’s shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...